The Latest in Diabetes

Internal Medicine News

Evidence links common endocrine-disrupting chemicals to obesity, diabetes, reproductive disorders

September 28, 2015

Internal Medicine News

ICAAC: 2015 brings three major systematic reviews of diabetic foot infection therapy

September 26, 2015

Internal Medicine News

Long-acting insulin degludec – and degludec combo drug – win FDA nod

September 26, 2015

Internal Medicine News

EASD: SGLT2 inhibitors show potential in 1DM despite DKA concern

September 25, 2015

Internal Medicine News

In type 2 diabetes, pump therapy costs more but saves much

September 24, 2015

Internal Medicine News

Empagliflozin’s triumph respins FDA’s diabetes drug mandate

September 21, 2015

Internal Medicine News

Diabetic foot ulcer: Early closure post debridement best

September 21, 2015

Internal Medicine News

‘Artificial beta-cell’ insulin systems post more positive data

September 18, 2015

Internal Medicine News

EASD: SGLT2 inhibitor empagliflozin cuts CV risk in patients with type 2 diabetes

September 18, 2015

Internal Medicine News

When stepping up type 2 treatment, GLP-1 agonists have the edge

September 17, 2015

Internal Medicine News

No difference in long-term cost for diabetes treatment with bariatric surgery

September 17, 2015

Internal Medicine News

Liraglutide/metformin targets glycemic goal in type 2 diabetes

September 16, 2015

Internal Medicine News

Long-acting basal insulin controls HbA1c as well as glargine

September 16, 2015

Internal Medicine News

EASD: Intranasal glucagon reverses hypoglycemia in children and adolescents

September 16, 2015

Internal Medicine News

EASD: High HbA1c linked to elevated dementia risk in patients with 2DM

September 16, 2015